Clinical Trial: A Study of SRSD384 in Overweight or Obese Participants

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557355) titled 'A Study of SRSD384 in Overweight or Obese Participants' on April 22.

Brief Summary: This is a two-part study, intended to investigate the safety, tolerability, characteristics of PK and PD of single SC dose of SRSD384 alone in overweight or obese participants (Part A) and in combination with tirzepatide in overweight or obese participants with T2DM (Part B).

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Overweight , Obesity

Intervention: DRUG: SRSD384 injection

Administered S.C. per the protocol

DRUG: Placebo

Administered S.C. per the protocol

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sirius Th...